HMTV yields 27.97% · JNJ yields 2.13%● Live data
📍 HMTV pulled ahead of the other in Year 1
Combined, HMTV + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMTV + JNJ for your $10,000?
Hemisphere Media Group, Inc. operates as the Spanish-language media company. The company operates Pantaya, a subscription streaming service of Spanish-language media with approximately million subscribers; Cinelatino, a cable movie network with approximately 17.1 million subscribers in the United States, Latin America, and Canada; WAPA, a broadcast television network and television content producer; WAPA.TV, a news and entertainment website, as well as mobile apps, featuring content produced by WAPA; and WAPA Deportes, a sports television network in Puerto Rico. It also operates WAPA America, a cable television network that serves approximately 3.3 million subscribers in the United States; and Pasiones, a cable television network, which showcases telenovelas and serialized dramas to approximately 3.7 million subscribers in the United States and 15.4 million subscribers in Latin America. In addition, the company operates Centroamerica TV, a cable television network that provides news and entertainment, and soccer programming to approximately 3.2 million subscribers in the United States; and Television Dominicana, a cable television network, which offers news and entertainment programs to approximately 2.2 million subscribers in the United States. Further, it operates Snap Media, a distributor of content to broadcast and cable television networks; and over-the-top, and subscription and advertising video-on-demand platforms in Latin America; and REMEZCLA: a digital media company targeting English-speaking and the bilingual U.S. Hispanic millennials. The company was incorporated in 2013 and is headquartered in Coral Gables, Florida. As of September 13, 2022, Hemisphere Media Group, Inc. was taken private.
Full HMTV Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.